PURPOSE:
The number of applications in which roboticassisted surgery are used has grown steadily, especially in the fields of transoral, reconstructive and microsurgery. We evaluate the robot in cleft palate repair by conducting a feasibility study.
METhOdS:
Eight cadaveric human heads were used to evaluate cleft palate repair and radical intravelar-veloplasty utilizing the Da Vinci robot. Dissection of the levator veli palatini with the robot was randomized to either the right or left side. The opposite side of the velum acted as the control and was dissected by hand. Times required to complete subsequent steps of the procedure using the robot were measured.
RESULTS:
The time (seconds±SD) to perform a robotic dissection (491 ± 90) of the levator muscle was equivalent to the time taken to perform a dissection by hand (552 ± 140; p: 0.349). Time for repair of the levator (309 ± 106) and oral-mucosa closure (1185 ± 165) decreased with experience, while nasal-mucosa closure (980 ± 190) did not. Based on average times, repair of a cleft palate with intravelar-veloplasty would take 57.4 minutes when all the steps are performed using the robot. Both the surgeon and the assistant felt the instrumentation was ergonomic and visibility was excellent. While there was no haptic feedback capability, no notable complications occurred.
CONCLUSIONS:
Robotic-assisted repair of cleft palate defects with intravelar-veloplasty is feasible on adult cadavers and may provide enhanced visualization and ergonomics. There is a trend towards faster operating time with experience on the robot. Although untested in the pediatric population, robotic technology may offer a safe and effective technique. constructs that remained viable for more than 28 days in static culture. However, without exposing the vascular lining cells to flow, their functionality and in vivo stability are suboptimal. Here, we "prime" the constructs by dynamically perfusing them and determine how flow induced shear stress optimizes the endoluminal surfaces of our tissueengineered vessels.
Utilizing Shear Stress to

MATERIALS ANd METhOdS:
Pluronic F127 fibers, 1.5 mm in diameter, were sacrificed in type I collagen, creating a central looped microchannel. 100μL polyculture cell suspension mixture of 5 x 10 6 cells/mL of human foreskin fibroblasts and 5 x 10 6 cells/mL of human aortic smooth muscle cells was seeded into the microchannel. The following day, a 100μL cell suspension of 5 x 10 5 cells/mL of human placental pericytes and 5 x 10 6 cells/mL of human umbilical vein endothelial cells was seeded into the microchannel. All constructs underwent daily media changes in static culture for 7 days, and then half were perfused at 10 dynes/cm 2 for an additional 7 days. After 14 days, scaffolds were fixed and processed.
RESULTS:
After 7 and 14 days of culture, constructs formed intact endoluminal linings along the microchannel with increasing thickness over time. CD31 expressing endothelial cells were noted along the luminal surface after 7 days and throughout the endoluminal lining after 14 days, establishing a neointima. Constructs undergoing static and dynamic culture had robust, vascular linings that spanned the entire microchannel. However, dynamic constructs had a 59% thicker lining in the channel (p=0.0057). Ki67 staining demonstrated statistically significant increased cell proliferation in constructs that experienced dynamic perfusion suggesting stimulation by the shear stress (p=0.0429).
CONCLUSION:
Shear stress through dynamic perfusion was used to optimize the development of a layer of vascular lining cells to provide a non-thrombogenic surface to allow continuous blood flow in these tissue engineered vessels. Exposing pre-vascularized engineered tissues to controlled perfusion produces vessels with architecture that more accurately recapitulates the in vivo phenotype and provides a surface for thrombosisfree blood flow, allowing for surgical implantation via microanastomosis.
